Nanjo Y. (Nanjo et al., 2013) has suggested that the use of colistin sulfate (subcutaneously injected at 1.0 mg per mouse) can reduce the levels of TNF-α, IL-6 and IL-1β in LPS-induced sepsis mouse model and lead to decreased toxicity. The gene discussed is IL6; the disease is Sepsis.